1. Home
  2. MAIN vs KRYS Comparison

MAIN vs KRYS Comparison

Compare MAIN & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

HOLD

Current Price

$62.28

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$245.73

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIN
KRYS
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.3B
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
MAIN
KRYS
Price
$62.28
$245.73
Analyst Decision
Hold
Strong Buy
Analyst Count
7
9
Target Price
$61.57
$214.22
AVG Volume (30 Days)
450.6K
272.8K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
6.84%
N/A
EPS Growth
9.38
275.72
EPS
6.03
6.66
Revenue
$561,290,000.00
$373,164,000.00
Revenue This Year
$5.53
$36.14
Revenue Next Year
$2.24
$41.80
P/E Ratio
$10.33
$37.07
Revenue Growth
5.92
54.51
52 Week Low
$47.00
$122.80
52 Week High
$67.77
$246.94

Technical Indicators

Market Signals
Indicator
MAIN
KRYS
Relative Strength Index (RSI) 68.31 85.32
Support Level $57.57 $213.83
Resistance Level $63.21 $241.65
Average True Range (ATR) 1.04 7.92
MACD 0.65 2.15
Stochastic Oscillator 88.34 97.04

Price Performance

Historical Comparison
MAIN
KRYS

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: